Replies to post #4962982 on BB's Stock Haven

[Natural Trader]

$BTTX good otc stock now : Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status

[Natural Trader]

$BTTX .013 :In February 2024, the FDA granted Better Therapeutics Breakthrough Device Designation for its novel Cognitive Behavioral Therapy (CBT) platform intended to treat adults with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH. We are actively seeking strategic partnerships to expedite the development and commercialization of this therapy.